Dermatology Conference Brief

To view this email as a web page, click here.

Today is the last day of the 2019 AAD Annual Meeting in Washington, D.C. Visit our conference page for our news reports from the meeting.

Treatments in the pipeline for psoriasis

Psoriasis treatment has expanded dramatically over the past decade, and the growth shows no signs of stopping. Andrew Blauvelt, M.D. discussed new drugs in the pipeline during American Academy of Dermatology Annual Meeting in Washington, D.C.

Real-world reasons biologics lose efficacy

Why do biologics lose efficacy over time? This physician discusses factors dermatologists should consider when they see this issue in their patients.

Vitiligo treatment offers lasting results

Longer-lasting treatment for vitiligo could be available within the next few years, according to research presented at the American Academy of Dermatology Spring Meeting in Washington, D.C.

For live updates from the meeting, be sure to follow us at @DermTimesNow on Twitter!

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

CONNECT